Implantation Device to House Insulin Secreting Cells as a Treatment for Diabetes
§ The device provides a long-term, effective solution for the care of diabetes § More convenient, cost-effective than current methods of glucose monitoring and management § Requires only one minimally-invasive out-patient procedure (implantation of the small device under the skin) § The cell-based device automatically responds to changes in blood glucose, and eliminates the burden on patients to continuously self-monitor and administer insulin
Current treatments for diabetes include regular blood glucose monitoring and insulin injection by standard needles, insulin pens and pumps, or lancing devices. These methods are time-consuming, costly, and may fail to achieve ideal glucose levels. UCI researchers have designed a long-term solution to diabetes (both Type 1 and 2) management that is highly effective and convenient. The solution is an implantable device that regulates insulin levels without continuous patient or physician intervention. The novel device is implanted under the patient’s skin and houses exogenous insulin-producing cells. The construction of the device is such that it will become properly vascularized by the patient’s own tissues. The physical features of the device allow the housed cells to have access to nutrients and oxygen which maintains the health and functionality of the cells, and also puts the cells into contact with the patient’s blood to efficiently monitor glucose levels and respond accordingly. Prototype developed and successfully demonstrated in vivo in a murine diabetes models.
20160082236
Additional Technologies by these Inventors Tech ID/UC Case 22903/2012-203-0 Related Cases 2012-203-0 UC QuickStart
QuickStart Licensing
美國
